Illumina, Inc. (NASDAQ: ILMN) and Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced an expanded collaboration to advance precision oncology ...

Dr. Cande Rogert discusses emerging trends in sequencing and how new genomic technologies are shaping multiomics and clinical ...

Illumina fundamentals are improving, with FY26 expected to return to positive growth and enable operating leverage. Find out ...

Illumina Inc. (NASDAQ:ILMN) is one of the 8 Best Quality Stocks to Buy According to Hedge Funds. Illumina Inc. (NASDAQ:ILMN) is one of the best quality stocks to buy according to hedge funds. On March ...

Labcorp Holdings (NYSE:LH) is expanding its New York footprint through the acquisition of assets and operations from Crouse Health and Lab Alliance. The company is also extending its collaboration ...

Located on the Buffalo Niagara Medical Campus and the first next-generation sequencing service provider in the region, UB's Genomics and Bioinformatics Core Facility provides high-quality services ...

Stanford develops protein-to-DNA method enabling high-throughput protein sequencing Technique detects up to 1,000 times more ...

This paper provides a valuable observation that imiquimod, a compound often used to induce a psoriasis-like skin inflammation in mice, has a TLR7-independent effect acting through the unfolded protein ...

I tried the $950 blood test Silicon Valley thinks can revolutionize cancer screening. The science—and my results—tell a ...

A study found that in about 10 percent of patients, WGS picked up on clinically actionable information other panels missed.

Robot adoption is advancing rapidly, driven by declining costs, rising demand, and the integration of artificial intelligence ...